LFSC Holdings Information

LFSC is an equity ETF with a total of 38 individual holdings. The top holdings are Travere Therapeutics stock at 7.35%, Guardant Health at 6.12%, LivaNova at 5.40%, TransMedics Group at 5.23%, and Cogent Biosciences at 4.33%.

Total Holdings

Top 10 Percentage

48.11%

Asset Class

Equity

ETF Category

Health

Assets

75.24M

PE Ratio

n/a

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	TVTX	Travere Therapeutics, Inc.	7.35%	161,925
2	GH	Guardant Health, Inc.	6.12%	47,810
3	LIVN	LivaNova PLC	5.40%	78,914
4	TMDX	TransMedics Group, Inc.	5.23%	31,222
5	COGT	Cogent Biosciences, Inc.	4.33%	222,995
6	BBIO	BridgeBio Pharma, Inc.	4.21%	49,929
7	MDGL	Madrigal Pharmaceuticals, Inc.	4.10%	6,403
8	NKTR	Nektar Therapeutics	3.93%	53,769
9	RDNT	RadNet, Inc.	3.93%	37,312
10	WVE	Wave Life Sciences Ltd.	3.49%	322,171
11	ATEC	Alphatec Holdings, Inc.	3.41%	128,317
12	UTHR	United Therapeutics Corporation	3.34%	5,543
13	SVRA	Savara Inc.	3.14%	578,067
14	CORT	Corcept Therapeutics Incorporated	3.10%	30,068
15	KALV	KalVista Pharmaceuticals, Inc.	2.99%	201,761
16	SLNO	Soleno Therapeutics, Inc.	2.92%	46,283
17	MIRM	Mirum Pharmaceuticals, Inc.	2.85%	30,187
18	INSM	Insmed Incorporated	2.82%	11,208
19	SYRE	Spyre Therapeutics, Inc.	2.72%	88,346
20	TRVI	Trevi Therapeutics, Inc.	2.69%	187,527
21	RARE	Ultragenyx Pharmaceutical Inc.	2.68%	62,545
22	KRRO	Korro Bio, Inc.	2.44%	55,953
23	MMSI	Merit Medical Systems, Inc.	2.30%	19,562
24	AXSM	Axsome Therapeutics, Inc.	2.07%	11,315
25	COLL	Collegium Pharmaceutical, Inc.	2.06%	42,606

Showing 25 of 38 holdings

Subscribe to see the full list

Activate Now

As of Nov 5, 2025